GROGAN DONNA ROY has filed 12 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 5370 shares of C4 Therapeutics, Inc. ($CCCC) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 5370 | $2.70 | 71,512.0000 | 96,914,418 | 8.12% | 0.01% |
| Jan. 2, 2026 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 7513 | $1.93 | 66,142.0000 | 96,914,418 | 12.81% | 0.01% |
| Oct. 1, 2025 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 6740 | $2.15 | 58,629.0000 | 70,989,661 | 12.99% | 0.01% |
| July 1, 2025 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 9609 | $1.51 | 51,889.0000 | 70,989,661 | 22.73% | 0.01% |
| June 18, 2025 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| April 1, 2025 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 9581 | $1.44 | 42,280.0000 | 70,989,661 | 29.30% | 0.01% |
| Jan. 2, 2025 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 3757 | $3.66 | 32,699.0000 | 0 | 12.98% | 0.00% |
| Oct. 1, 2024 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 2474 | $5.56 | 28,942.0000 | 0 | 9.35% | 0.00% |
| July 1, 2024 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 2836 | $4.85 | 26,468.0000 | 0 | 12.00% | 0.00% |
| June 20, 2024 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 1697 | $8.10 | 23,632.0000 | 0 | 7.74% | 0.00% |
| Jan. 2, 2024 | C4 Therapeutics, Inc. | $CCCC | GROGAN DONNA ROY | Director | A | Common Stock | 2108 | $6.52 | 21,935.0000 | 0 | 10.63% | 0.00% |